acetovanillone and muromonab-cd3
acetovanillone has been researched along with muromonab-cd3 in 1 studies
Research
Studies (1)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Bender, B; Closhen, D; Friedl, P; Gerigk, M; Kuhlmann, CR; Luhmann, HJ; Zehendner, CM | 1 |
Other Studies
1 other study(ies) available for acetovanillone and muromonab-cd3
Article | Year |
---|---|
MK801 blocks hypoxic blood-brain-barrier disruption and leukocyte adhesion.
Topics: Acetophenones; Animals; Astrocytes; Blood-Brain Barrier; Brain; Calcium; Cell Adhesion; Cell Hypoxia; Cells, Cultured; Coculture Techniques; Dizocilpine Maleate; Electric Impedance; Endothelial Cells; Enzyme Inhibitors; Excitatory Amino Acid Antagonists; Glutamic Acid; Leukocytes; Macrocyclic Compounds; Oxazoles; Oxygen; Reactive Oxygen Species; Ryanodine; Swine | 2009 |